PolTREG’s PTG-007 Treg Therapy Shows Long-Term Remission in Type-1 Diabetes, Up to 12 Years in Some Patients

PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 years A proportion of patients remained insulin-independent for up t...

September 09, 2024 | Monday | News
New Antibody Discovery Led by Texas Biomed Professor Could Revolutionize COVID Treatment

A discovery led in part by a Texas Biomedical Research Institute (Texas Biomed) Associate Professor has opened the possibility of large-scale manufacturi...

September 06, 2024 | Friday | News
Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm St...

September 04, 2024 | Wednesday | News
Nxera Pharma to Receive $35 Million Milestone Payment from Neurocrine Following Successful Phase 2 Schizophrenia Trial

Nxera Pharma Co – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Bi...

September 03, 2024 | Tuesday | News
Novavax Prepares to Launch Protein-Based COVID-19 Vaccine in Thousands of U.S. Locations with Pre-Filled Syringes

Novavax expects pre-filled syringes will be broadly available in thousands of locations across the U.S. Novavax's vaccine is the only protein-based op...

September 02, 2024 | Monday | News
GSK's Nucala Becomes First and Only Biologic Approved in Japan for CRSwNP with Four-Weekly Dosing Schedule

Nucala is the first and only biologic in Japan with a four-weekly dosing schedule for this condition Chronic rhinosinusitis with nasal polyps (CRSwNP)...

August 29, 2024 | Thursday | News
Phanes Therapeutics Secures FDA Orphan Drug Designation for PT217 in Treating Neuroendocrine Carcinoma

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today th...

August 19, 2024 | Monday | News
Parexel’s Greenhouse Gas Reduction Targets Earn SBTi Validation, Marking Key Milestone in Net-Zero Commitment

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...

August 13, 2024 | Tuesday | News
Shanghai Junshi Biosciences’ Toripalimab sNDA Accepted by NMPA for First-Line Treatment of Advanced Melanoma

Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of ...

August 13, 2024 | Tuesday | News
Merck Life Science India and Aragen Life Sciences Sign Landmark MoU to Accelerate mAb Manufacturing and Innovation

Merck Life Science in India  announced the signing of a Memorandum of Understanding (MoU) with Aragen Life Sciences, a leading provider of R&D a...

August 09, 2024 | Friday | News
Vertex Pharmaceuticals Secures Landmark Reimbursement Deal with NHS England for First CRISPR Gene-Edited Therapy

Vertex Pharmaceuticals (Nasdaq: VRTX) announced  a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT...

August 09, 2024 | Friday | News
Parse Biosciences Partners with Prisma Biotech to Expand Single-Cell Sequencing Reach in Asia-Pacific

-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...

August 08, 2024 | Thursday | News
PacBio's HiFi Sequencing Technology Chosen for Singapore's Largest Long-Read Sequencing Project

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PR...

August 06, 2024 | Tuesday | News
NurExone Biologic Inc Achieves GMP-Grade Manufacturing for ExoPTEN Nanodrug’s siRNA Sequence

NurExone Biologic Inc, a pioneering biopharmaceutical company, is thrilled to announce an important milestone in its regenerative medicine efforts. The C...

August 02, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close